Operaciones Alector, Inc. - ALEC CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | 0.07 | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.025457% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.003235% | ||||||||
| Horario tarifa nocturna | 21:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | USD | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | United States of America | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
Alector Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Estadísticas clave
| Cierre previo* | 6.8 |
| Abrir* | 6.85 |
| Cambio de 1 año* | -20.99% |
| Rango del día* | 6.79 - 7.08 |
| Rango de 52 semanas | 5.76-13.50 |
| Volumen medio (10 días) | 441.93K |
| Volumen medio (3 meses) | 11.45M |
| Capitalización de mercado | 593.47M |
| Ratio P/E | -100.00K |
| Acciones en circulación | 83.35M |
| Ingresos | 125.69M |
| EPS | -1.58 |
| Dividendo (Rendimiento %) | N/A |
| Beta | 0.78 |
| Próxima fecha de resultados | Aug 2, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|---|---|---|---|---|---|
| Jun 2, 2023 | 7.08 | 0.30 | 4.42% | 6.78 | 7.09 | 6.77 |
| Jun 1, 2023 | 6.80 | -0.47 | -6.46% | 7.27 | 7.35 | 6.64 |
| May 31, 2023 | 7.40 | 0.14 | 1.93% | 7.26 | 7.71 | 7.26 |
| May 30, 2023 | 7.32 | -0.16 | -2.14% | 7.48 | 7.62 | 7.26 |
| May 26, 2023 | 7.57 | 0.29 | 3.98% | 7.28 | 7.59 | 7.28 |
| May 25, 2023 | 7.34 | -0.14 | -1.87% | 7.48 | 7.57 | 7.29 |
| May 24, 2023 | 7.62 | 0.13 | 1.74% | 7.49 | 7.65 | 7.48 |
| May 23, 2023 | 7.73 | 0.25 | 3.34% | 7.48 | 7.96 | 7.48 |
| May 22, 2023 | 7.63 | 0.15 | 2.01% | 7.48 | 7.79 | 7.48 |
| May 19, 2023 | 7.56 | 0.07 | 0.93% | 7.49 | 7.69 | 7.48 |
| May 18, 2023 | 7.46 | 0.13 | 1.77% | 7.33 | 7.68 | 7.25 |
| May 17, 2023 | 7.59 | -0.01 | -0.13% | 7.60 | 7.62 | 7.34 |
| May 16, 2023 | 7.58 | -0.14 | -1.81% | 7.72 | 7.73 | 7.46 |
| May 15, 2023 | 7.89 | 0.65 | 8.98% | 7.24 | 7.94 | 7.23 |
| May 12, 2023 | 7.32 | -0.02 | -0.27% | 7.34 | 7.34 | 7.08 |
| May 11, 2023 | 7.33 | -0.16 | -2.14% | 7.49 | 7.49 | 7.19 |
| May 10, 2023 | 7.55 | -0.10 | -1.31% | 7.65 | 7.93 | 7.24 |
| May 9, 2023 | 7.87 | 0.09 | 1.16% | 7.78 | 7.92 | 7.56 |
| May 8, 2023 | 7.89 | 0.50 | 6.77% | 7.39 | 7.97 | 7.34 |
| May 5, 2023 | 7.37 | 0.74 | 11.16% | 6.63 | 7.42 | 6.63 |
Alector, Inc. Events
| Hora (UTC) (UTC) | País | Evento |
|---|---|---|
| Wednesday, June 14, 2023 | ||
| Hora (UTC) (UTC) 15:00 | País US
| Evento Alector Inc Annual Shareholders Meeting Alector Inc Annual Shareholders MeetingForecast -Previous - |
| Friday, June 16, 2023 | ||
| Hora (UTC) (UTC) 15:00 | País US
| Evento Alector Inc Annual Shareholders Meeting Alector Inc Annual Shareholders MeetingForecast -Previous - |
| Wednesday, August 2, 2023 | ||
| Hora (UTC) (UTC) 10:59 | País US
| Evento Q2 2023 Alector Inc Earnings Release Q2 2023 Alector Inc Earnings ReleaseForecast -Previous - |
| Monday, November 6, 2023 | ||
| Hora (UTC) (UTC) 10:59 | País US
| Evento Q3 2023 Alector Inc Earnings Release Q3 2023 Alector Inc Earnings ReleaseForecast -Previous - |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos totales | 133.617 | 207.085 | 21.098 | 21.219 | 27.677 |
| Ingresos | 133.617 | 207.085 | 21.098 | 21.219 | 27.677 |
| Gastos totales de explotación | 271.451 | 244.445 | 216.272 | 135.623 | 84.965 |
| Gastos de venta/general/administración Gastos, total | 61.033 | 55.038 | 59.403 | 35.095 | 11.934 |
| Investigación y desarrollo | 210.418 | 189.407 | 156.869 | 100.528 | 73.031 |
| Ingresos de explotación | -137.834 | -37.36 | -195.174 | -114.404 | -57.288 |
| Otros, netos | 7.778 | 1.031 | 4.946 | 9.019 | 5.04 |
| Ingresos netos antes de impuestos | -130.056 | -36.329 | -190.228 | -105.385 | -52.248 |
| Ingresos netos después de impuestos | -130.056 | -36.329 | -190.228 | -105.385 | -52.248 |
| Beneficio neto antes de partidas extra. Elementos | -130.056 | -36.329 | -190.228 | -105.385 | -52.248 |
| Ingresos netos | -133.31 | -36.329 | -190.228 | -105.385 | -52.248 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -130.056 | -36.329 | -190.228 | -105.385 | -52.248 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -133.31 | -36.329 | -190.228 | -105.385 | -52.248 |
| Beneficio neto diluido | -133.31 | -36.329 | -190.228 | -105.385 | -52.248 |
| Promedio ponderado de acciones diluidas | 82.4676 | 80.4169 | 77.7588 | 61.7345 | 68.8712 |
| BPA diluido sin partidas extraordinarias | -1.57706 | -0.45176 | -2.44639 | -1.70707 | -0.75863 |
| Dividends per Share - Common Stock Primary Issue | |||||
| BPA normalizado diluido | -1.57706 | -0.45176 | -2.44381 | -1.68763 | -0.75863 |
| Total de partidas extraordinarias | -3.254 | 0 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Ingresos totales | 16.549 | 14.44 | 14.852 | 79.851 | 24.474 |
| Ingresos | 16.549 | 14.44 | 14.852 | 79.851 | 24.474 |
| Gastos totales de explotación | 66.664 | 69.878 | 62.6 | 70.376 | 68.597 |
| Gastos de venta/general/administración Gastos, total | 14.777 | 15.385 | 14.252 | 15.842 | 15.554 |
| Investigación y desarrollo | 51.887 | 54.493 | 48.348 | 54.534 | 53.043 |
| Ingresos de explotación | -50.115 | -55.438 | -47.748 | 9.475 | -44.123 |
| Otros, netos | 5.159 | 3.731 | 2.333 | 1.45 | 0.264 |
| Ingresos netos antes de impuestos | -44.956 | -51.707 | -45.415 | 10.925 | -43.859 |
| Ingresos netos después de impuestos | -44.956 | -51.707 | -45.415 | 10.925 | -43.859 |
| Beneficio neto antes de partidas extra. Elementos | -44.956 | -51.707 | -45.415 | 10.925 | -43.859 |
| Ingresos netos | -45.857 | -52.428 | -46.148 | 9.883 | -44.617 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -44.956 | -51.707 | -45.415 | 10.925 | -43.859 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -45.857 | -52.428 | -46.148 | 9.883 | -44.617 |
| Beneficio neto diluido | -45.857 | -52.428 | -46.148 | 9.883 | -44.617 |
| Promedio ponderado de acciones diluidas | 83.1023 | 82.7665 | 82.6028 | 82.5884 | 82.1022 |
| BPA diluido sin partidas extraordinarias | -0.54097 | -0.62473 | -0.5498 | 0.13228 | -0.5342 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| BPA normalizado diluido | -0.54097 | -0.62473 | -0.5498 | 0.13228 | -0.5342 |
| Total de partidas extraordinarias | -0.901 | -0.721 | -0.733 | -1.042 | -0.758 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 726.435 | 749.713 | 421.511 | 357.437 | 293.176 |
| Efectivo e inversiones a corto plazo | 712.851 | 735.251 | 413.308 | 353.073 | 290.408 |
| Efectivo y Equivalentes | 154.323 | 329.152 | 49.969 | 89.641 | 65.47 |
| Total deudores, neto | 2.587 | 7.391 | 0 | ||
| Accounts Receivable - Trade, Net | 2.587 | 7.391 | 0 | ||
| Prepaid Expenses | 10.997 | 7.071 | 8.203 | 4.364 | 2.768 |
| Total Assets | 787.648 | 814.658 | 488.251 | 421.913 | 308.359 |
| Property/Plant/Equipment, Total - Net | 53.332 | 57.899 | 62.651 | 62.328 | 10.937 |
| Property/Plant/Equipment, Total - Gross | 75.944 | 75.185 | 73.608 | 67.741 | 12.838 |
| Accumulated Depreciation, Total | -22.612 | -17.286 | -10.957 | -5.413 | -1.901 |
| Other Long Term Assets, Total | 7.881 | 7.046 | 4.089 | 2.148 | 4.246 |
| Total Current Liabilities | 93.809 | 139.555 | 68.088 | 61.97 | 47.948 |
| Accounts Payable | 4.189 | 4.749 | 3.004 | 0.278 | 0.126 |
| Accrued Expenses | 41.389 | 44.003 | 41.198 | 31.527 | 12.902 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 48.231 | 90.803 | 23.886 | 30.165 | 34.92 |
| Total Liabilities | 573.206 | 513.934 | 220.721 | 227.17 | 195.237 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 479.397 | 374.379 | 152.633 | 165.2 | 147.289 |
| Total Equity | 214.442 | 300.724 | 267.53 | 194.743 | 113.122 |
| Redeemable Preferred Stock | 0 | ||||
| Preferred Stock - Non Redeemable, Net | 210.52 | ||||
| Common Stock | 0.008 | 0.008 | 0.008 | 0.007 | 0.001 |
| Additional Paid-In Capital | 798.696 | 748.036 | 676.956 | 414.414 | 17.078 |
| Retained Earnings (Accumulated Deficit) | -579.687 | -446.377 | -410.048 | -219.82 | -114.435 |
| Total Liabilities & Shareholders’ Equity | 787.648 | 814.658 | 488.251 | 421.913 | 308.359 |
| Total Common Shares Outstanding | 82.8957 | 81.9862 | 79.3163 | 69.0529 | 68.8712 |
| Inversiones a corto plazo | 558.528 | 406.099 | 363.339 | 263.432 | 224.938 |
| Other Equity, Total | -4.575 | -0.943 | 0.614 | 0.142 | -0.042 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 686.002 | 726.435 | 774.963 | 827.021 | 890.926 |
| Efectivo e inversiones a corto plazo | 669.329 | 712.851 | 758.306 | 808.855 | 868.571 |
| Efectivo y Equivalentes | 195.555 | 154.323 | 184.231 | 172.265 | 454.62 |
| Inversiones a corto plazo | 473.774 | 558.528 | 574.075 | 636.59 | 413.951 |
| Prepaid Expenses | 11.974 | 10.997 | 10.166 | 9.35 | 9.536 |
| Total Assets | 748.342 | 787.648 | 837.038 | 889.672 | 954.457 |
| Property/Plant/Equipment, Total - Net | 52.064 | 53.332 | 54.819 | 55.26 | 56.127 |
| Other Long Term Assets, Total | 10.276 | 7.881 | 7.256 | 7.391 | 7.404 |
| Total Current Liabilities | 99.3 | 93.809 | 160.889 | 149.409 | 142.878 |
| Accounts Payable | 3.126 | 4.189 | 4.546 | 4.646 | 6.752 |
| Accrued Expenses | 34.401 | 41.389 | 36.659 | 37.769 | 40.515 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 61.773 | 48.231 | 119.684 | 106.994 | 95.611 |
| Total Liabilities | 565.327 | 573.206 | 583.934 | 601.156 | 686.92 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 466.027 | 479.397 | 423.045 | 451.747 | 544.042 |
| Total Equity | 183.015 | 214.442 | 253.104 | 288.516 | 267.537 |
| Common Stock | 0.008 | 0.008 | 0.008 | 0.008 | 0.008 |
| Additional Paid-In Capital | 810.75 | 798.696 | 787.097 | 775.843 | 762.458 |
| Retained Earnings (Accumulated Deficit) | -625.544 | -579.687 | -527.259 | -481.111 | -490.994 |
| Other Equity, Total | -2.199 | -4.575 | -6.742 | -6.224 | -3.935 |
| Total Liabilities & Shareholders’ Equity | 748.342 | 787.648 | 837.038 | 889.672 | 954.457 |
| Total Common Shares Outstanding | 83.3518 | 82.8957 | 82.7009 | 82.5449 | 82.3247 |
| Total deudores, neto | 4.699 | 2.587 | 6.491 | 8.816 | 12.819 |
| Accounts Receivable - Trade, Net | 4.699 | 2.587 | 6.491 | 8.816 | 12.819 |
| Property/Plant/Equipment, Total - Gross | 75.944 | ||||
| Accumulated Depreciation, Total | -22.612 |
- Anual
- Trimestral
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | -133.31 | -36.329 | -190.228 | -105.385 | -52.248 |
| Efectivo de actividades de explotación | -20.329 | 298.551 | -166.734 | -99.308 | 127.464 |
| Efectivo de actividades de explotación | 5.714 | 6.329 | 5.87 | 3.775 | 1.019 |
| Partidas no monetarias | 47.741 | 44.87 | 32.846 | 14.576 | 4.331 |
| Cambios en el capital circulante | 59.526 | 283.681 | -15.222 | -12.274 | 174.362 |
| Efectivo de actividades de inversión | -159.014 | -49.663 | -105.051 | -48.874 | -224.119 |
| Gastos de capital | -4.117 | -3.247 | -5.032 | -15.265 | -1.884 |
| Efectivo procedente de actividades de financiación | 4.514 | 30.295 | 232.113 | 172.353 | 131.146 |
| Emisión (retiro) de acciones, neto | 4.514 | 30.295 | 232.113 | 172.445 | 133.05 |
| Variación neta de la tesorería | -174.829 | 279.183 | -39.672 | 24.171 | 34.491 |
| Otras partidas de flujo de caja de inversión, total | -154.897 | -46.416 | -100.019 | -33.609 | -222.235 |
| Elementos de flujo de caja de financiación | -0.092 | -1.904 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -45.857 | -133.31 | -80.882 | -34.734 | -44.617 |
| Cash From Operating Activities | -48.548 | -20.329 | 28.596 | 77.649 | 135.091 |
| Cash From Operating Activities | 1.36 | 5.714 | 4.32 | 2.973 | 1.589 |
| Non-Cash Items | 9.121 | 47.741 | 37.491 | 26.478 | 13.179 |
| Changes in Working Capital | -13.172 | 59.526 | 67.667 | 82.932 | 164.94 |
| Cash From Investing Activities | 88.701 | -159.014 | -177.395 | -237.925 | -12.106 |
| Capital Expenditures | -1.025 | -4.117 | -3.351 | -1.436 | -0.692 |
| Other Investing Cash Flow Items, Total | 89.726 | -154.897 | -174.044 | -236.489 | -11.414 |
| Cash From Financing Activities | 1.079 | 4.514 | 3.878 | 3.389 | 2.483 |
| Issuance (Retirement) of Stock, Net | 1.079 | 4.514 | 3.878 | 3.389 | 2.483 |
| Net Change in Cash | 41.232 | -174.829 | -144.921 | -156.887 | 125.468 |
| Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
|---|---|---|---|---|---|---|
| Polaris Venture Partners | Venture Capital | 14.2214 | 11853817 | 0 | 2022-12-31 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 7.6632 | 6387376 | 1675436 | 2023-03-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 7.6628 | 6387074 | 39552 | 2023-03-31 | LOW |
| Rosenthal (Armon) | Individual Investor | 6.3256 | 5272486 | 36885 | 2023-03-31 | |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 6.3119 | 5261040 | 32555 | 2023-03-31 | LOW |
| EcoR1 Capital, LLC | Hedge Fund | 4.8668 | 4056548 | 0 | 2023-03-31 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.2775 | 3565331 | 335814 | 2023-03-31 | LOW |
| Braidwell LP | Hedge Fund | 3.8467 | 3206315 | 2481291 | 2023-03-31 | HIGH |
| Gerngross (Tillman U.) | Individual Investor | 3.1296 | 2608610 | -9459 | 2023-03-31 | |
| Federated Hermes Global Investment Management Corp. | Investment Advisor/Hedge Fund | 2.4493 | 2041539 | -1758626 | 2023-03-31 | LOW |
| JP Morgan Asset Management | Investment Advisor | 2.0972 | 1748087 | 124606 | 2023-03-31 | LOW |
| Franklin Advisers, Inc. | Investment Advisor/Hedge Fund | 1.8983 | 1582281 | 550 | 2023-03-31 | LOW |
| BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.7655 | 1471560 | 131498 | 2023-03-31 | LOW |
| Point72 Asset Management, L.P. | Hedge Fund | 1.5997 | 1333342 | 1333342 | 2023-03-31 | HIGH |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.4621 | 1218724 | 26435 | 2023-03-31 | LOW |
| Deerfield Management Company, L.P. | Hedge Fund | 1.266 | 1055192 | 0 | 2023-03-31 | MED |
| Euclidean Capital, L.L.C. | Investment Advisor | 1.1768 | 980894 | 0 | 2023-03-31 | LOW |
| Baker Bros. Advisors LP | Hedge Fund | 1.1576 | 964851 | 282860 | 2023-03-31 | LOW |
| Two Sigma Investments, LP | Hedge Fund | 1.0067 | 839105 | 192518 | 2023-03-31 | HIGH |
| King (Robert Siang-Shu) | Individual Investor | 0.863 | 719296 | 169669 | 2023-03-31 |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group535K+
Traders
87K+
Clientes activos mensualmente
$113M+
Volumen mensual de inversión
$64M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
Comisión de la operación
0
- 1:1
Apalancamiento
1:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
Alector, Inc. Company profile
Sobre Alector Inc
Alector, Inc. es una empresa biofarmacéutica en fase clínica. La empresa se centra en la inmunoneurología, un enfoque terapéutico para el tratamiento de la neurodegeneración. La empresa se dedica a desarrollar terapias diseñadas para contrarrestar estas patologías mediante el restablecimiento de una función inmunitaria saludable en el cerebro. Su plataforma de investigación y descubrimiento de fármacos aprovecha conjuntos de datos genéticos humanos, herramientas avanzadas de bioinformática e imagen, y conocimientos sobre neurodegeneración e inmunología para identificar el sistema inmunitario. La empresa ha avanzado en el desarrollo clínico de cuatro productos candidatos, AL001, AL002, AL003 y AL101. Su primer candidato a producto, AL001, es un anticuerpo monoclonal recombinante humanizado que aumenta los niveles de progranulina (PGRN) en el cerebro de pacientes con demencia frontotemporal portadora de progranulina (FTD-GRN). Su AL002 se dirige al receptor desencadenante expresado en las células mieloides 2 (TREM2) para aumentar la funcionalidad de la señalización de TREM2 y potenciar la activación de las células de la microglía.
El precio actual de la acción Alector, Inc. en tiempo real es 7.09 USD. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: Alcoa, BJs Restaurants, Inc., EMCORE, ContraFect Corporation, Academy Sports and Outdoors, Inc. y Hennessy Ad. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
| Industry: | Bio Therapeutic Drugs |
131 Oyster Point Blvd., Suite 600
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 535.000 traders de todo el mundo que eligen operar con Capital.com